Quintiles Addresses Cloud Computing Security Concerns - Applied Clinical Trials

ADVERTISEMENT

See our 2013 Buyers Guide Digital Edition.
Quintiles Addresses Cloud Computing Security Concerns

Source: Applied Clinical Trials

We usually don't post press releases on our site about awards, however, this one for Quintiles looks at cloud computing and security, so we thought it a bit different. Quintiles was named to the CSO40—CSO is a content site for security professions ls in a broad range of disciplines. Specifically they focus on information security, physical security, business continuity, identity and access management, loss prevention and more. The Award recognizes 40 organizations for security projects and initiatives that demonstration outstanding business value and thought leadership. Quintiles' Trusted Cloud Services Model was recognized.

The security issues for cloud computing are a debate in our industry. But Quintiles has addressed these concerns ensuring cloud service providers are subject to the same level of security assurance as internal systems.Quintiles' approach builds upon its global security framework and application security assessment program, extending security controls directly into cloud service providers’ environments.

Read the full release here.

ADVERTISEMENT

blog comments powered by Disqus

ADVERTISEMENT

UPCOMING CONFERENCES

8th Annual Forum on Transparency and Aggregate Spend 2014
Washington, DC
August 18-20, 2014

eSource Data in Clinical Investigations
Philadelphia, PA
August 20-21, 2014

Pharmacovigilance 2014
Philadelphia, PA
September 10-11, 2014

Collaborative Research Summit
Philadelphia, PA
October 15-16, 2014

See All Conferences >>

Survey
As it creates a plan to implement the US biosimilar pathway, should FDA:
Borrow heavily from EMA's pathway program?
Borrow lightly from EMA's pathway program?
Create entirely its own pathway program?
Borrow heavily from EMA's pathway program?
86%
Borrow lightly from EMA's pathway program?
7%
Create entirely its own pathway program?
7%
View Results
Untitled Document
Source: Applied Clinical Trials,
Click here